Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
EditorialEditorial

Is Macrophage Activation Syndrome in Kawasaki Disease Underrecognized?

Valentina Natoli, Silvia Rosina and Angelo Ravelli
The Journal of Rheumatology February 2021, 48 (2) 162-164; DOI: https://doi.org/10.3899/jrheum.200361
Valentina Natoli
1V. Natoli, MD, Università degli Studi di Genova, Genoa;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Silvia Rosina
2S. Rosina, MD, PhD, IRCCS Istituto Giannina Gaslini, Genoa, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angelo Ravelli
3A. Ravelli, MD, Università degli Studi di Genova, and IRCCS Istituto Giannina Gaslini, Genoa, Italy, and Sechenov First Moscow State Medical University, Moscow, Russian Federation.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: angeloravelli{at}gaslini.org
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

Article Figures & Data

Tables

    • View popup
    Table 1.

    Comparison of typical clinical and laboratory features of Kawasaki disease and macrophage activation syndrome (MAS).

    FeatureKawasaki DiseaseMAS
    Fever patternRemittentContinuous
    RashErythematous maculopapular, scarlatiniform or erythema multiforme-likePetechial, purpuric, or erythematous maculopapular
    LymphadenopathyCervical and unilateralGeneralized
    Hepatomegaly±++
    Splenomegaly–++
    Arthralgias/arthritis±–
    Serositis+–
    HemorrhagesCracked bleeding lips only+
    CNS involvement++ Common: irritability with aseptic meningitis. Rare: transient peripheral facial nerve palsy, profound sensorineural hearing loss+ Headache, lethargy, disorientation, hallucinations, seizures, coma
    White blood cell count↑↑↓
    HemoglobinNormal or ↓↓
    Platelet countNormal or ↑↓
    ESR↑↑*Normal or ↑
    CRP↑↑↑
    TransaminasesNormal or ↑↑↑
    BilirubinNormal or ↑↑
    Lactate dehydrogenaseNormal or ↑↑↑
    TriglyceridesNormal↑
    AlbuminNormal or ↓↓↓
    Fibrinogen↑** ↓
    D-dimer↑↑↑
    • ↵* ESR tends to decrease in MAS.

    • ↵** The absolute value of fibrinogen may be normal or still elevated in MAS; however, its decreasing trend helps with the recognition of MAS versus another inflammatory process. CNS: central nervous system; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein.

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 48, Issue 2
1 Feb 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Is Macrophage Activation Syndrome in Kawasaki Disease Underrecognized?
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Is Macrophage Activation Syndrome in Kawasaki Disease Underrecognized?
Valentina Natoli, Silvia Rosina, Angelo Ravelli
The Journal of Rheumatology Feb 2021, 48 (2) 162-164; DOI: 10.3899/jrheum.200361

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Is Macrophage Activation Syndrome in Kawasaki Disease Underrecognized?
Valentina Natoli, Silvia Rosina, Angelo Ravelli
The Journal of Rheumatology Feb 2021, 48 (2) 162-164; DOI: 10.3899/jrheum.200361
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Trends in Acute Coronary Syndromes in Systemic Lupus Erythematosus: Are We Moving in the Right Direction?
  • What Predicts Initial Biologic Disease-Modifying Antirheumatic Drug Failure in Psoriatic Arthritis and How Common Is It?
  • Changes in Modern Care for Juvenile Idiopathic Arthritis: How Much Does This Affect Health-Related Quality of Life?
Show more Editorial

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire